Eila C. Skinner
Urologic oncologist, Urologist
Thomas A. Stamey Research Professor in Urology
View Professional Summary »
For Referring Physicians:
Select a Resource
For Referring Physicians:
Select a Resource
Professional Summary »
Specializing In »
Practice Locations »
Patient Ratings »
Referring Physicians »
Biography
Dr. Skinner received her undergraduate degree in Human Biology from Stanford and MD from Keck USC Medical School. She completed a residency in Urology at LAC+USC Medical Center, and a fellowship in Urologic Oncology under Dr. Donald Skinner at the Norris Cancer Center at USC. She was on the faculty at USC from 1990 through 2012. She was recruited to Stanford University to become Chair of the Department of Urology in May 2012.
Dr. Skinner has received a number of awards including a Stop Cancer career development award, numerous teaching awards and listing in “Best Doctors” for over a decade. Her primary focus has been in the surgical treatment of locally advanced bladder cancer and is a nationally recognized expert in bladder reconstruction and continent urinary diversion. She has active ongoing clinical trials in the treatment of bladder cancer and other urologic malignancies.
View Full Biography »
Professional Summary
Professional Education
- Medical Education: University of Southern California Keck School of Medicine Registrar (1983) CA
- Board Certification: American Board of Urology, Urology (1992)
- Residency: USC/LAC Medical Center (1988) CA
- Fellowship: USC Norris Comprehensive Cancer Center (1990) CA
- Internship: USC/LAC Medical Center (1984) CA
- Board Certification, American Board of Urology, Urology (1992)
- Fellowship, USC Norris Comprehensive Cancer Center, Urologic Oncology (1990)
- Residency, LAC+USC Medical Center, Urology (1988)
- Internship, LAC+USC Medical Center, General Surgery (1984)
- Medical Education, Keck USC School of Medicine, Medicine (1983)
- AB, Stanford Universtiy, Human Biology (1976)
Honors & Awards
- Alpha Omega Alpha, USC School of Medicine (1982)
- Faculty Teacher of the Year, USC Department of Urology (1991, 1994, 1997, 2005)
- Janet M. Glasgow Award for Academic Excellence, USC School of Medicine (1983)
- Outstanding Teacher Award, Keck USC School of Medicine (1997, 98, 2000, 02, 03, 06, 11)
- Phi Beta Kappa, Stanford University (1976)
Administrative Appointments
- Chair, Department of Urology (2012 - Present)
Publications
-
Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, or cutaneous or urethral Kock pouch
Hart, S., Skinner, E. C., Meyerowitz, B. E., Boyd, S., Lieskovsky, G., & Skinner, D. G. (1999). Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, or cutaneous or urethral Kock pouch. JOURNAL OF UROLOGY, 162(1), 77–81. -
Quality of life with reconstruction.
Skinner, E. C. (2001). Quality of life with reconstruction. Seminars in Urologic Oncology, 19(1), 56–58. -
Sexuality and intimacy following radical prostatectomy: Patient and partner perspectives
Perez, M. A., Skinner, E. C., & Meyerowitz, B. E. (2002). Sexuality and intimacy following radical prostatectomy: Patient and partner perspectives. HEALTH PSYCHOLOGY, 21(3), 288–293. -
High-risk localized prostate cancer: primary surgery and adjuvant therapy
Skinner, E. C., & Glode, L. M. (2003). High-risk localized prostate cancer: primary surgery and adjuvant therapy. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 21(3), 219–227. -
Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder
Daneshmand, S., Stein, J. P., Lesser, T., Quek, M. L., Nichols, P. W., Miranda, G., … Skinner, D. G. (2004). Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder. JOURNAL OF UROLOGY, 172(1), 81–84. -
Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women
Quek, M. L., Ginsberg, D. A., Wilson, S., Skinner, E. C., Stein, J. P., & Skinner, D. G. (2004). Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women. JOURNAL OF UROLOGY, 172(1), 219–221. -
Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: Long-term results
Daneshmand, S., Quek, M. L., Stein, J. P., Lieskovsky, G., Cai, J., Pinski, J., … Skinner, D. G. (2004). Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: Long-term results. JOURNAL OF UROLOGY, 172(6), 2252–2255. -
Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy
Quek, M. L., Stein, J. P., Nichols, P. W., Cai, J., Miranda, G., Groshen, S., … Skinner, D. G. (2005). Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. JOURNAL OF UROLOGY, 174(1), 103–106. -
Quality of life after cystectomy and urinary diversion: An evidence based analysis
Gerharz, E. W., Mansson, A., Hunt, S., Skinner, E. C., & Mansson, W. (2005). Quality of life after cystectomy and urinary diversion: An evidence based analysis. JOURNAL OF UROLOGY, 174(5), 1729–1736. -
A critical analysis of perioperative mortality from radical cystectomy
Quek, M. L., Stein, J. P., Daneshmand, S., Miranda, G., Thangathurai, D., Roffey, P., … Skinner, D. G. (2006). A critical analysis of perioperative mortality from radical cystectomy. JOURNAL OF UROLOGY, 175(3), 886–889. -
Surgical benchmarks for the treatment of invasive bladder cancer
Skinner, E. C., Stein, J. P., & Skinner, D. G. (2007). Surgical benchmarks for the treatment of invasive bladder cancer. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 25(1), 66–71. -
Radical cystectomy with extended lymphadenectomy: Evaluating separate package versus en bloc submission for node positive bladder cancer
Stein, J. P., Penson, D. F., Cai, J., Miranda, G., Skinner, E. C., Dunn, M. A., … Skinner, D. G. (2007). Radical cystectomy with extended lymphadenectomy: Evaluating separate package versus en bloc submission for node positive bladder cancer. JOURNAL OF UROLOGY, 177(3), 876–881. -
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
Hall, M. C., Chang, S. S., Dalbagni, G., Pruthi, R. S., Seigne, J. D., Skinner, E. C., … Schellhammer, P. F. (2007). Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update. JOURNAL OF UROLOGY, 178(6), 2314–2330. -
The best treatment for high-grade T1 bladder cancer is cystectomy
Skinner, E. C. (2007). The best treatment for high-grade T1 bladder cancer is cystectomy. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 25(6), 523–25. -
Does reflux in orthotopic diversion matter? A randomized prospective comparison of the Studer and T-pouch ileal neobladders
Skinner, E. C., & Skinner, D. G. (2009). Does reflux in orthotopic diversion matter? A randomized prospective comparison of the Studer and T-pouch ileal neobladders. WORLD JOURNAL OF UROLOGY, 27(1), 51–55. -
Extended lymphadenectomy in bladder cancer
Dorin, R. P., & Skinner, E. C. (2010). Extended lymphadenectomy in bladder cancer. CURRENT OPINION IN UROLOGY, 20(5), 414–20. -
Early Complications of Cystectomy After High Dose Pelvic Radiation
Eisenberg, M. S., Dorin, R. P., Bartsch, G., Cai, J., Miranda, G., & Skinner, E. C. (2010). Early Complications of Cystectomy After High Dose Pelvic Radiation. JOURNAL OF UROLOGY, 184(6), 2264–2269. -
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort
Svatek, R. S., Shariat, S. F., Novara, G., Skinner, E. C., Fradet, Y., Bastian, P. J., … Dinney, C. P. (2011). Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU INTERNATIONAL, 107(6), 898–904. -
Choosing the right urinary diversion: Patient's choice or surgeon's inclination?
Skinner, E. C. (2011). Choosing the right urinary diversion: Patient's choice or surgeon's inclination? UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 29(5), 473–475. -
Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.
Kassouf, W., Svatek, R. S., Shariat, S. F., Novara, G., Lerner, S. P., Fradet, Y., … Skinner, E. C. (2013). Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urologic Oncology, 31(4), 480–86. -
Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types
Davis-Dao, C. A., Siegmund, K. D., Vandenberg, D. J., Skinner, E. C., Coetzee, G. A., Thomas, D. C., … Cortessis, V. K. (2011). Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types. CARCINOGENESIS, 32(8), 1238–43. -
Factors influencing post-recurrence survival in bladder cancer following radical cystectomy
Mitra, A. P., Quinn, D. I., Dorff, T. B., Skinner, E. C., Schuckman, A. K., Miranda, G., … Daneshmand, S. (2012). Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU INTERNATIONAL, 109(6), 846–854. -
Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative Study
Zehnder, P., Studer, U. E., Skinner, E. C., Dorin, R. P., Cai, J., Roth, B., … Skinner, D. G. (2011). Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative Study. JOURNAL OF UROLOGY, 186(4), 1261–1268. -
Robotic and Laparoscopic High Extended Pelvic Lymph Node Dissection During Radical Cystectomy: Technique and Outcomes
Desai, M. M., Berger, A. K., Brandina, R. R., Zehnder, P., Simmons, M., Aron, M., … Gill, I. S. (2012). Robotic and Laparoscopic High Extended Pelvic Lymph Node Dissection During Radical Cystectomy: Technique and Outcomes. EUROPEAN UROLOGY, 61(2), 350–355. -
Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy
Huang, E. Y.-H., Skinner, E. C., Boyd, S. D., Cai, J., Miranda, G., & Daneshmand, S. (2012). Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy. WORLD JOURNAL OF UROLOGY, 30(6), 741–745. -
Critical Evaluation of the American Joint Committee on Cancer TNM Nodal Staging System in Patients with Lymph Node-Positive Disease after Radical Cystectomy
Bruins, H. M., Dorin, R. P., Rubino, B., Miranda, G., Cai, J., Daneshmand, S., & Skinner, E. C. (2012). Critical Evaluation of the American Joint Committee on Cancer TNM Nodal Staging System in Patients with Lymph Node-Positive Disease after Radical Cystectomy. EUROPEAN UROLOGY, 62(4), 671–76. -
SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guerin
Skinner, E. C., Goldman, B., Sakr, W. A., Petrylak, D. P., Lenz, H.-J., Lee, C. T., … Thompson, I. M. (2013). SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guerin. JOURNAL OF UROLOGY, 190(4), 1200–1204. -
INDICATIONS FOR LOWER URINARY-TRACT RECONSTRUCTION IN WOMEN AFTER CYSTECTOMY FOR BLADDER-CANCER - A PATHOLOGICAL REVIEW OF FEMALE CYSTECTOMY SPECIMENS
Stein, J. P., Cote, R. J., Freeman, J. A., Esrig, D., Elmajian, D. A., Groshen, S., … Skinner, D. G. (1995). INDICATIONS FOR LOWER URINARY-TRACT RECONSTRUCTION IN WOMEN AFTER CYSTECTOMY FOR BLADDER-CANCER - A PATHOLOGICAL REVIEW OF FEMALE CYSTECTOMY SPECIMENS. JOURNAL OF UROLOGY, 154(4), 1329–1333. -
Complications of the afferent antireflux valve mechanism in the kock ileal reservoir
Stein, J. P., Freeman, J. A., Esrig, D., Elmajian, D. A., Tarter, T. H., Skinner, E. C., … Skinner, D. G. (1996). Complications of the afferent antireflux valve mechanism in the kock ileal reservoir. JOURNAL OF UROLOGY, 155(5), 1579–1583. -
Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion
Esrig, D., Freeman, C. A., Elmajian, D. A., Stein, J. P., Chen, S. C., Groshen, S., … Skinner, D. G. (1996). Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. JOURNAL OF UROLOGY, 156(3), 1071–1076. -
Management of complex urologic injuries
Skinner, E. C., Parisky, Y. R., & Skinner, D. G. (1996). Management of complex urologic injuries. SURGICAL CLINICS OF NORTH AMERICA, 76(4), 861-? -
Orthotopic lower urinary tract reconstruction in women using the kock ileal neobladder: Updated experience in 34 patients
Stein, J. P., Grossfeld, G. D., Freeman, J. A., Esrig, D., Ginsberg, D. A., Cote, R. J., … Skinner, D. G. (1997). Orthotopic lower urinary tract reconstruction in women using the kock ileal neobladder: Updated experience in 34 patients. JOURNAL OF UROLOGY, 158(2), 400–405. -
Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile AIDS
Perez, M. A., Meyerowitz, B. E., Lieskovsky, G., Skinner, D. G., Reynolds, B., & Skinner, E. C. (1997). Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile AIDS. UROLOGY, 50(5), 740–746. -
25-year experience in the management of invasive bladder cancer by radical cystectomy
Skinner, D. G., Stein, J. P., Lieskovsky, G., Skinner, E. C., Boyd, S. D., Figueroa, A., … Groshen, S. (1998). 25-year experience in the management of invasive bladder cancer by radical cystectomy. Presented at the 6th Heinrich Warner Symposium on Invasive Bladder Carcinoma - Progress in Basic Research, Surgical and Medical Therapy, HAMBURG,GERMANY: ELSEVIER SCIENCE BV. -
Radical cystectomy for elderly patients with bladder carcinoma - An updated experience with 404 patients
Figueroa, A. J., Stein, J. P., Dickinson, M., Skinner, E. C., Thangathurai, D., Mikhail, M. S., … Skinner, D. G. (1998). Radical cystectomy for elderly patients with bladder carcinoma - An updated experience with 404 patients. CANCER, 83(1), 141–147. -
The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels
Cote, R. J., Skinner, E. C., Salem, C. E., Mertes, S. J., Stanczyk, F. Z., Henderson, B. E., … Ross, R. K. (1998). The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels. BRITISH JOURNAL OF CANCER, 78(3), 413–418. -
Hydronephrosis as a prognostic indicator in bladder cancer patients
Haleblian, G. E., Skinner, E. C., Dickinson, M. G., Lieskovsky, G., Boyd, S. D., & Skinner, D. G. (1998). Hydronephrosis as a prognostic indicator in bladder cancer patients. JOURNAL OF UROLOGY, 160(6), 2011–2014. -
Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study
Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. (2011). European Urology, 60. -
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy
Shariat, S. F., Svatek, R. S., Tilki, D., Skinner, E., Karakiewicz, P. I., Capitanio, U., … Fradet, Y. (2010). International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU INTERNATIONAL, 105(10), 1402–1412. -
Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer
Sonpavde, G., Khan, M. M., Lerner, S. P., Svatek, R. S., Novara, G., Karakiewicz, P. I., … Shariat, S. F. (2011). Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer. JOURNAL OF UROLOGY, 185(2), 456–461. -
Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients
Novara, G., Svatek, R. S., Karakiewicz, P. I., Skinner, E., Ficarra, V., Fradet, Y., … Shariat, S. F. (2010). Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients. JOURNAL OF UROLOGY, 183(6), 2165–2170. -
DOES THE RACIAL-ETHNIC VARIATION IN PROSTATE-CANCER RISK HAVE A HORMONAL BASIS
Ross, R. K., Coetzee, G. A., Reichardt, J., Skinner, E., & Henderson, B. E. (1995). DOES THE RACIAL-ETHNIC VARIATION IN PROSTATE-CANCER RISK HAVE A HORMONAL BASIS. CANCER, 75(7), 1778–1782. -
Alterations in circulating levels of androgens and PSA during treatment with finasteride in men at high risk for prostate cancer
Stanczyk, F. Z., Skinner, E. C., Mertes, S., Spahn, M. F., Lobo, R. A., & Ross, R. K. (1996). Alterations in circulating levels of androgens and PSA during treatment with finasteride in men at high risk for prostate cancer. Presented at the 2nd International Hormonal Carcinogenesis Symposium, STOCKHOLM,SWEDEN: SPRINGER-VERLAG. -
Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort
Fritsche, H.-M., Burger, M., Svatek, R. S., Jeldres, C., Karakiewicz, P. I., Novara, G., … Shariat, S. F. (2010). Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort. EUROPEAN UROLOGY, 57(2), 300–309. -
Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome
Tilki, D., Reich, O., Karakiewicz, P. I., Novara, G., Kassouf, W., Erguen, S., … Shariat, S. F. (2010). Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome. EUROPEAN UROLOGY, 58(1), 112–117. -
Characteristics and Outcomes of Patients With Clinical Carcinoma In Situ Only Treated With Radical Cystectomy: An International Study of 243 Patients
Tilki, D., Reich, O., Svatek, R. S., Karakiewicz, P. I., Kassouf, W., Novara, G., … Shariat, S. F. (2010). Characteristics and Outcomes of Patients With Clinical Carcinoma In Situ Only Treated With Radical Cystectomy: An International Study of 243 Patients. JOURNAL OF UROLOGY, 183(5), 1757–1763. -
Stage pT0 at Radical Cystectomy Confers Improved Survival: An International Study of 4,430 Patients
Tilki, D., Svatek, R. S., Novara, G., Seitz, M., Godoy, G., Karakiewicz, P. I., … Shariat, S. F. (2010). Stage pT0 at Radical Cystectomy Confers Improved Survival: An International Study of 4,430 Patients. JOURNAL OF UROLOGY, 184(3), 888–894. -
pT3 Substaging is a Prognostic Indicator for Lymph Node Negative Urothelial Carcinoma of the Bladder
Tilki, D., Svatek, R. S., Karakiewicz, P. I., Novara, G., Seitz, M., Sonpavde, G., … Shariat, S. F. (2010). pT3 Substaging is a Prognostic Indicator for Lymph Node Negative Urothelial Carcinoma of the Bladder. JOURNAL OF UROLOGY, 184(2), 470–474. -
Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes after Surgery
Nuhn, P., Bastian, P. J., Novara, G., Svatek, R. S., Karakiewicz, P. I., Skinner, E., … Shariat, S. F. (2011). Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes after Surgery. UROLOGIA INTERNATIONALIS, 87(1), 42–48. -
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy
Sonpavde, G., Khan, M. M., Svatek, R. S., Lee, R., Novara, G., Tilki, D., … Shariat, S. F. (2011). Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy. BJU INTERNATIONAL, 108(5), 687–92. -
Prognostic Risk Stratification of Pathological Stage T3N0 Bladder Cancer After Radical Cystectomy
Sonpavde, G., Khan, M. M., Svatek, R. S., Lee, R., Novara, G., Tilki, D., … Shariat, S. F. (2011). Prognostic Risk Stratification of Pathological Stage T3N0 Bladder Cancer After Radical Cystectomy. JOURNAL OF UROLOGY, 185(4), 1216–21. -
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy
Chromecki, T. F., Mauermann, J., Cha, E. K., Svatek, R. S., Fajkovic, H., Karakiewicz, P. I., … Shariat, S. F. (2012). Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy. WORLD JOURNAL OF UROLOGY, 30(6), 753–59. -
Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy
Bruins, H. M., Wopat, R., Mitra, A. P., Cai, J., Miranda, G., Skinner, E. C., & Daneshmand, S. (2013). Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy. BJU INTERNATIONAL, 111(3B), E37–E42. -
URINARY-DIVERSION
Skinner, D. G., Skinner, E. C., Lieskovsky, G., & Boyd, S. D. (1987). URINARY-DIVERSION. CURRENT PROBLEMS IN SURGERY, 24(7), 401–471. -
RADICAL CYSTECTOMY
Skinner, E. C., Lieskovsky, G., & Skinner, D. G. (1991). RADICAL CYSTECTOMY. AKTUELLE UROLOGIE, 22(5), AR1–AR14. -
A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer
Mitra, A. P., Skinner, E. C., Miranda, G., & Daneshmand, S. (2013). A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. BJU INTERNATIONAL, 111(2), 240–48. -
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion
Hautmann, R. E., Abol-Enein, H., Davidsson, T., Gudjonsson, S., Hautmann, S. H., Holm, H. V., … Xu, A. (2013). ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion. EUROPEAN UROLOGY, 63(1), 67–80. -
RADICAL CYSTECTOMY IN REGIONALLY ADVANCED BLADDER-CANCER
Lerner, S. P., Skinner, E., & Skinner, D. G. (1992). RADICAL CYSTECTOMY IN REGIONALLY ADVANCED BLADDER-CANCER. UROLOGIC CLINICS OF NORTH AMERICA, 19(4), 713–723. -
Continent and orthotopic urinary diversion following radical cystectomy. Should these reconstructive procedures now be considered standard of care?
Boyd, S. D., Skinner, E., Lieskovsky, G., & Skinner, D. G. (1995). Continent and orthotopic urinary diversion following radical cystectomy. Should these reconstructive procedures now be considered standard of care? Surgical Oncology Clinics of North America, 4(2), 277–286. -
Incidental Prostate Cancer in Patients with Bladder Urothelial Carcinoma: Comprehensive Analysis of 1,476 Radical Cystoprostatectomy Specimens
Bruins, H. M., Djaladat, H., Ahmadi, H., Sherrod, A., Cai, J., Miranda, G., … Daneshmand, S. (2013). Incidental Prostate Cancer in Patients with Bladder Urothelial Carcinoma: Comprehensive Analysis of 1,476 Radical Cystoprostatectomy Specimens. JOURNAL OF UROLOGY, 190(5), 1704–9. -
Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
Stein, J. P., Lieskovsky, G., Cote, R., Groshen, S., Feng, A. C., Boyd, S., … Skinner, D. G. (2001). Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. JOURNAL OF CLINICAL ONCOLOGY, 19(3), 666–675. -
Combination of Molecular Alterations and Smoking Intensity Predicts Bladder Cancer Outcome A Report From the Los Angeles Cancer Surveillance Program
Mitra, A. P., Castelao, J. E., Hawes, D., Tsao-Wei, D. D., Jiang, X., Shi, S.-R., … Cote, R. J. (2013). Combination of Molecular Alterations and Smoking Intensity Predicts Bladder Cancer Outcome A Report From the Los Angeles Cancer Surveillance Program. CANCER, 119(4), 756–765. -
Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the response
Kang, T. Y., Nichols, P., Skinner, E., Groshen, S., Valin, G., Ye, W., & Raghavan, D. (2007). Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the response. BJU INTERNATIONAL, 99(5), 1024–1027. -
Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy.
Bruins, H. M., Wopat, R., Mitra, A. P., Cai, J., Miranda, G., Skinner, E. C., & Daneshmand, S. (2013). Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy. BJU International, 111(3), E37–42. -
XANTHOGRANULOMATOUS PYELONEPHRITIS - CLINICAL FINDINGS AND SURGICAL CONSIDERATIONS
Eastham, J., Ahlering, T., & Skinner, E. (1994). XANTHOGRANULOMATOUS PYELONEPHRITIS - CLINICAL FINDINGS AND SURGICAL CONSIDERATIONS. UROLOGY, 43(3), 295–299. -
Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades
Zehnder, P., Studer, U. E., Skinner, E. C., Thalmann, G. N., Miranda, G., Roth, B., … Gill, I. S. (2013). Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU INTERNATIONAL, 112(2), E51–E58. -
Prevention of prostate cancer with finasteride.
Ross, R. K., Skinner, E., & Cote, R. J. (2003). Prevention of prostate cancer with finasteride. New England Journal of Medicine, 349(16), 1569–1572. -
Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California
Fairey, A. S., Daneshmand, S., Quinn, D., Dorff, T., Dorin, R., Lieskovsky, G., … Skinner, E. C. (2013). Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 31(8), 1737–43. -
A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine
Birkhahn, M., Mitra, A. P., Williams, A. J., Barr, N. J., Skinner, E. C., Stein, J. P., … Cote, R. J. (2013). A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine. EUROPEAN JOURNAL OF CANCER, 49(15), 3159–68. -
THE RATIONALE FOR EN-BLOC PELVIC LYMPH-NODE DISSECTION FOR BLADDER-CANCER PATIENTS WITH NODAL METASTASES - LONG-TERM RESULTS
Lerner, S. P., Skinner, D. G., Lieskovsky, G., Boyd, S. D., Groshen, S. L., Ziogas, A., … Hopwood, B. (1993). THE RATIONALE FOR EN-BLOC PELVIC LYMPH-NODE DISSECTION FOR BLADDER-CANCER PATIENTS WITH NODAL METASTASES - LONG-TERM RESULTS. JOURNAL OF UROLOGY, 149(4), 758–765. -
Urinary Functional Outcome Following Radical Cystoprostatectomy and Ileal Neobladder Reconstruction in Male Patients
Ahmadi, H., Skinner, E. C., Simma-Chiang, V., Miranda, G., Cai, J., Penson, D. F., & Daneshmand, S. (2013). Urinary Functional Outcome Following Radical Cystoprostatectomy and Ileal Neobladder Reconstruction in Male Patients. JOURNAL OF UROLOGY, 189(5), 1782–88. -
Reproductive Organ Involvement in Female Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer
Djaladat, H., Bruins, H. M., Miranda, G., Cai, J., Skinner, E. C., & Daneshmand, S. (2012). Reproductive Organ Involvement in Female Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer. JOURNAL OF UROLOGY, 188(6), 2134–2138. -
Null Association Between Histology of First and Second Primary Malignancies in Men With Bilateral Testicular Germ Cell Tumors
Thomas, J. P. J., Davis-Dao, C., Lewinger, J. P., Siegmund, K. D., Hamilton, A. S., Daneshmand, S., … Cortessis, V. K. (2013). Null Association Between Histology of First and Second Primary Malignancies in Men With Bilateral Testicular Germ Cell Tumors. AMERICAN JOURNAL OF EPIDEMIOLOGY, 178(8), 1240–45. -
Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study.
Bruins, H. M., Skinner, E. C., Dorin, R. P., Ahmadi, H., Djaladat, H., Miranda, G., … Daneshmand, S. (2014). Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study. Urologic Oncology, 32(1), 24 e13–9. -
Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: Oncological outcomes
Djaladat, H., Mitra, A. P., Miranda, G., Skinner, E. C., & Daneshmand, S. (2013). Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: Oncological outcomes. INTERNATIONAL JOURNAL OF UROLOGY, 20(12), 1229–33. -
Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients.
Mitra, A. P., Skinner, E. C., Schuckman, A. K., Quinn, D. I., Dorff, T. B., & Daneshmand, S. (2014). Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. Urologic Oncology, 32(1), 52 e1–9. -
Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era.
Fairey, A. S., Daneshmand, S., Skinner, E. C., Schuckman, A., Cai, J., & Lieskovsky, G. (2014). Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era. Urologic Oncology, 32(2), 85–91. -
Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.
Fairey, A. S., Daneshmand, S., Wang, L., Schuckman, A., Lieskovsky, G., Djaladat, H., … Skinner, E. C. (2014). Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy. Urologic Oncology, 32(2), 110–16. -
Urinary functional outcomes in female neobladder patients.
Bartsch, G., Daneshmand, S., Skinner, E. C., Syan, S., Skinner, D. G., & Penson, D. F. (2014). Urinary functional outcomes in female neobladder patients. World Journal of Urology, 32(1), 221–28. -
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis.
Messer, J. C., Shariat, S. F., Dinney, C. P., Novara, G., Fradet, Y., Kassouf, W., … Svatek, R. S. (2014). Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. Urology, 83(4), 863–68. -
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy
Zehnder, P., Studer, U. E., Daneshmand, S., Birkhaeuser, F. D., Skinner, E. C., Roth, B., … Gill, I. S. (2014). Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. BJU INTERNATIONAL, 113(4), 554–560. -
The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer.
Djaladat, H., Bruins, H. M., Miranda, G., Cai, J., Skinner, E. C., & Daneshmand, S. (2014). The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer. BJU International, 113(6), 887–93. -
Comprehensive molecular characterization of urothelial bladder carcinoma
Weinstein, J. N., Akbani, R., Broom, B. M., Wang, W., Verhaak, R. G. W., McConkey, D., … Eley, G. (2014). Comprehensive molecular characterization of urothelial bladder carcinoma. NATURE, 507(7492), 315–22. -
Is extended lymphadenectomy of beneficial therapeutic value for T2 urothelial cancer?
Skinner, E. C., & Sagalowsky, A. I. (2014). Is extended lymphadenectomy of beneficial therapeutic value for T2 urothelial cancer? Journal of Urology, 191(5), 1206–8. -
Level III-IV Inferior Vena Caval Thrombectomy Without Cardiopulmonary Bypass: Long-Term Experience with Intrapericardial Control
Patil, M. B., Montez, J., Loh-Doyle, J., Cai, J., Skinner, E. C., Schuckman, A., … Daneshmand, S. (2014). Level III-IV Inferior Vena Caval Thrombectomy Without Cardiopulmonary Bypass: Long-Term Experience with Intrapericardial Control. JOURNAL OF UROLOGY, 192(3), 682–88. -
Endoscopic molecular imaging of human bladder cancer using a CD47 antibody.
Pan, Y., Volkmer, J.-P., Mach, K. E., Rouse, R. V., Liu, J.-J., Sahoo, D., … Liao, J. C. (2014). Endoscopic molecular imaging of human bladder cancer using a CD47 antibody. Science Translational Medicine, 6(260), 260ra148-? -
Endoscopic molecular imaging of human bladder cancer using a CD47 antibody
Pan, Y., Volkmer, J.-P., Mach, K. E., Rouse, R. V., Liu, J.-J., Sahoo, D., … Liao, J. C. (2014). Endoscopic molecular imaging of human bladder cancer using a CD47 antibody. SCIENCE TRANSLATIONAL MEDICINE, 6(260). -
Outcomes After Urothelial Recurrence in Bladder Cancer Patients Undergoing Radical Cystectomy
Mitra, A. P., Alemozaffar, M., Harris, B. N., Schuckman, A. K., Skinner, E. C., & Daneshmand, S. (2014). Outcomes After Urothelial Recurrence in Bladder Cancer Patients Undergoing Radical Cystectomy. UROLOGY, 84(6). -
Genitourinary cancer in the elderly
Raghavan, D., & Skinner, E. (2004). Genitourinary cancer in the elderly. SEMINARS IN ONCOLOGY, 31(2), 249–263. -
Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy.
Zehnder, P., Moltzahn, F., Daneshmand, S., Leahy, M., Cai, J., Miranda, G., … Gill, I. S. (2014). Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy. BJU International, 113(1), 65–69. -
Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis
Mitra, A. P., Bartsch, C. C., Bartsch, G., Miranda, G., Skinner, E. C., & Daneshmand, S. (2014). Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 32(2), 117–27. -
A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence
Su, S.-F., Abreu, A. L. de C., Chihara, Y., Tsai, Y., Andreu-Vieyra, C., Daneshmand, S., … Liang, G. (2014). A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence. CLINICAL CANCER RESEARCH, 20(7), 1978–89. -
Urinary Diversion: How Experts Divert
Hautmann, R. E., Abol-Enein, H., Lee, C. T., Mansson, W., Mills, R. D., Penson, D. F., … Volkmer, B. G. (2015). Urinary Diversion: How Experts Divert. UROLOGY, 85(1), 233–38. -
Best Practices in Robot-assisted Radical Cystectomy and Urinary Reconstruction: Recommendations of the Pasadena Consensus Panel
Wilson, T. G., Guru, K., Rosen, R. C., Wiklund, P., Annerstedt, M., Bochner, B. H., … Catto, J. (2015). Best Practices in Robot-assisted Radical Cystectomy and Urinary Reconstruction: Recommendations of the Pasadena Consensus Panel. EUROPEAN UROLOGY, 67(3), 363–75. -
A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma
Van Poppel, H., Da Pozzo, L., Albrecht, W., Matveev, V., Bono, A., Borkowski, A., … Sylvester, R. (2007). A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. EUROPEAN UROLOGY, 51(6), 1606–15. -
A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
Van Poppel, H., Da Pozzo, L., Albrecht, W., Matveev, V., Bono, A., Borkowski, A., … Sylvester, R. (2011). A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma. EUROPEAN UROLOGY, 59(4), 543–52. -
Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23
Schumacher, F. R., Wang, Z., Skotheim, R. I., Koster, R., Chung, C. C., Hildebrandt, M. A. T., … McGlynn, K. A. (2013). Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. HUMAN MOLECULAR GENETICS, 22(13), 2748–53. -
Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer
Mitra, A. P., Lam, L. L., Ghadessi, M., Erho, N., Vergara, I. A., Alshalalfa, M., … Black, P. C. (2014). Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 106(11). -
Meta-analysis identifies four new loci associated with testicular germ cell tumor
Chung, C. C., Kanetsky, P. A., Wang, Z., Hildebrandt, M. A. T., Koster, R., Skotheim, R. I., … Nathanson, K. L. (2013). Meta-analysis identifies four new loci associated with testicular germ cell tumor. NATURE GENETICS, 45(6), 680-? -
Reprogramming of the human intestinal epigenome by surgical tissue transposition
Lay, F. D., Triche, T. J., Tsai, Y. C., Su, S.-F., Martin, S. E., Daneshmand, S., … Jones, P. A. (2014). Reprogramming of the human intestinal epigenome by surgical tissue transposition. GENOME RESEARCH, 24(4), 545–53. -
Randomized Trial of Studer Pouch versus T-Pouch Orthotopic Ileal Neobladder in Patients with Bladder Cancer
Skinner, E. C., Fairey, A. S., Groshen, S., Daneshmand, S., Cai, J., Miranda, G., & Skinner, D. G. (2015). Randomized Trial of Studer Pouch versus T-Pouch Orthotopic Ileal Neobladder in Patients with Bladder Cancer. JOURNAL OF UROLOGY, 194(2), 433–39. -
Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel.
Wilson, T. G., Guru, K., Rosen, R. C., Wiklund, P., Annerstedt, M., Bochner, B. H., … Catto, J. (2015). Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel. European Urology, 67(3), 363–75. -
Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes
Zehnder, P., Moltzahn, F., Mitra, A. P., Cai, J., Miranda, G., Skinner, E. C., … Daneshmand, S. (2016). Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes. BJU INTERNATIONAL, 117(2), 253–59. -
Continent cutaneous diversion
Skinner, E. C. (2015). Continent cutaneous diversion. CURRENT OPINION IN UROLOGY, 25(6), 555–61. -
Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.
Seiler, R., Lam, L. L., Erho, N., Takhar, M., Mitra, A. P., Buerki, C., … Black, P. C. (2016). Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures. Journal of Urology, 196(4), 1036–41. -
Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind?
Leppert, J. T., Mittakanti, H. R., Thomas, I.-C., Lamberts, R. W., Sonn, G. A., Chung, B. I., … Brooks, J. D. (2016). Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind? Urology. -
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Chang, S. S., Boorjian, S. A., Chou, R., Clark, P. E., Daneshmand, S., Konety, B. R., … McKiernan, J. M. (2016). Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline. JOURNAL OF UROLOGY, 196(4), 1021–29. -
Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer.
Dorff, T. B., Schuckman, A. K., Schwartz, R., Rashad, S., Bulbul, A., Cai, J., … Quinn, D. I. (2016). Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer. Clinical Genitourinary Cancer, 14(5), 450–56 e1. -
Reconstruction With Pedicled Anterolateral Thigh Flap After Wide Local Excision of Penoscrotal Extramammary Paget's Disease: A Case Report and Comprehensive Literature Review.
Hunter, C. L., Skinner, E. C., & Lee, G. K. (2015). Reconstruction With Pedicled Anterolateral Thigh Flap After Wide Local Excision of Penoscrotal Extramammary Paget's Disease: A Case Report and Comprehensive Literature Review. Eplasty, 15. -
Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind?
Leppert, J. T., Mittakanti, H. R., Thomas, I.-C., Lamberts, R. W., Sonn, G. A., Chung, B. I., … Brooks, J. D. (2017). Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind? UROLOGY, 100, 65–71. -
Consolidative Radiotherapy in Metastatic Urothelial Cancer.
Shah, S., Zhang, C. A., Hancock, S., Fan, A., Skinner, E., & Srinivas, S. (2017). Consolidative Radiotherapy in Metastatic Urothelial Cancer. Clinical Genitourinary Cancer. -
Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center
Porter, J. B. (2017). Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center. Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center, 13(8), e673–e682. -
Incident CKD after Radical or Partial Nephrectomy.
Leppert, J. T., Lamberts, R. W., Thomas, I.-C. C., Chung, B. I., Sonn, G. A., Skinner, E. C., … Brooks, J. D. (2017). Incident CKD after Radical or Partial Nephrectomy. Journal of the American Society of Nephrology : JASN. -
Consolidative radiotherapy in metastatic urothelial cancer (MUC)
Srinivas, S., Narayanan, S., Fan, A. C., Hancock, S. L., & Skinner, E. C. (2016). Consolidative radiotherapy in metastatic urothelial cancer (MUC). JOURNAL OF CLINICAL ONCOLOGY, 34(2). -
Orthotopic Urinary Diversion for Women
Zlatev, D. V., & Skinner, E. C. (2018). Orthotopic Urinary Diversion for Women. UROLOGIC CLINICS OF NORTH AMERICA, 45(1), 49-+. -
Immunotherapy in Urothelial Cancer, Part 1: T-Cell Checkpoint Inhibition in Advanced or Metastatic Disease
Yu, S. S., Dorff, T. B., Ballas, L. K., Sadeghi, S., Skinner, E. C., & Quinn, D. I. (2017). Immunotherapy in Urothelial Cancer, Part 1: T-Cell Checkpoint Inhibition in Advanced or Metastatic Disease. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 15(6), 466–77. -
Immunotherapy in Urothelial Cancer, Part 2: Adjuvant, Neoadjuvant, and Adjunctive Treatment
Yu, S. S., Ballas, L. K., Skinner, E. C., Dorff, T. B., Sadeghi, S., & Quinn, D. I. (2017). Immunotherapy in Urothelial Cancer, Part 2: Adjuvant, Neoadjuvant, and Adjunctive Treatment. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 15(7), 543–51. -
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer
Harshman, L. C., Tripathi, A., Kaag, M., Efstathiou, J. A., Apolo, A. B., Hoffman-Censits, J. H., … Sridhar, S. S. (2018). Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer. CLINICAL GENITOURINARY CANCER, 16(3), 213–18. -
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
Parekh, D. J., Reis, I. M., Castle, E. P., Gonzalgo, M. L., Woods, M. E., Svatek, R. S., … Thompson, I. M. (2018). Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. LANCET, 391(10139), 2525–36. -
Readmission Rate and Causes at 90-Day after Radical Cystectomy in Patients on Early Recovery after Surgery Protocol
Altobelli, E., Buscarini, M., Gill, H. S., & Skinner, E. C. (2017). Readmission Rate and Causes at 90-Day after Radical Cystectomy in Patients on Early Recovery after Surgery Protocol. BLADDER CANCER, 3(1), 51–56. -
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma (vol 5, 68, 2017)
Kamat, A. M., Bellmunt, J., Galsky, M. D., Konety, B. R., Lamm, D. L., Langham, D., … Rosenberg, J. E. (2017). Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma (vol 5, 68, 2017). JOURNAL FOR IMMUNOTHERAPY OF CANCER, 5, 80. -
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
Kamat, A. M., Bellmunt, J., Galsky, M. D., Konety, B. R., Lamm, D. L., Langham, D., … Rosenberg, J. E. (2017). Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 5, 68. -
Can We Improve the Functional Outcomes of Orthotopic Diversion in Women?
Skinner, E. C., & Comiter, C. V. (2015). Can We Improve the Functional Outcomes of Orthotopic Diversion in Women? EUROPEAN UROLOGY, 68(4), 672–73. -
Exploring multidisciplinary practice patterns in the management of muscle invasive bladder cancer (MIBC) across the US and Canada in 2015.
Harshman, L. C., Kaag, M., Efstathiou, J. A., Apolo, A. B., Hoffman-Censits, J. H., Stadler, W. M., … Sridhar, S. S. (2016). Exploring multidisciplinary practice patterns in the management of muscle invasive bladder cancer (MIBC) across the US and Canada in 2015. JOURNAL OF CLINICAL ONCOLOGY, 34(2). -
Prognostic features for testicular cancers (TCs): Can this be gleaned from pathology reports?
Srinivas, S., Eisenberg, M., & Skinner, E. C. (2015). Prognostic features for testicular cancers (TCs): Can this be gleaned from pathology reports? JOURNAL OF CLINICAL ONCOLOGY, 33(15). -
Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men
Hussein, A. A., Sexton, K. J., May, P. R., Meng, M. V., Hosseini, A., Eun, D. D., … Guru, K. A. (2018). Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 32(11), 4458–64. -
Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.
Mitra, A. P., Fairey, A. S., Skinner, E. C., Boorjian, S. A., Frank, I., Schoenberg, M. P., … Daneshmand, S. (2018). Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. Urologic Oncology. -
Giant renal angiomyolipoma in a solitary kidney.
Sohlberg, E., Sun, A., Massoudi, R., Prado, K., & Skinner, E. (2018). Giant renal angiomyolipoma in a solitary kidney. The Canadian Journal of Urology, 25(6), 9614–16. -
Giant renal angiomyolipoma in a solitary kidney
Sohlberg, E., Sun, A., Massoudi, R., Prado, K., & Skinner, E. (2018). Giant renal angiomyolipoma in a solitary kidney. CANADIAN JOURNAL OF UROLOGY, 25(6), 9614–16. -
Treatment of Muscle-Invasive Bladder Cancer in Older Patients.
Skinner, E. C. (2016). Treatment of Muscle-Invasive Bladder Cancer in Older Patients. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, (36), e228–e233. -
Editorial Comment
Skinner, E. C. (2017). Editorial Comment. JOURNAL OF UROLOGY, 198(5), 1106. -
Treatment of Muscle-Invasive Bladder Cancer in Older Patients.
Skinner, E. C. (2016). Treatment of Muscle-Invasive Bladder Cancer in Older Patients. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, 35, e228–33. -
Is 42 days the 'magic number' for repeat transurethral resection of bladder tumour (TURBT)?
Skinner, E. C. (2015). Is 42 days the 'magic number' for repeat transurethral resection of bladder tumour (TURBT)? BJU INTERNATIONAL, 116(5), 678–79. -
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.
Parekh, D. J., Reis, I. M., Castle, E. P., Gonzalgo, M. L., Woods, M. E., Svatek, R. S., … Thompson, I. M. (2018). Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet (London, England), 391(10139), 2525–36. -
Improving care with portfolio of physician-led cancer quality measures at an academic center
Porter, J., Smith, A. S., Winget, M., Rosenthal, E. L., Seshadri, S. B., Vetteth, Y., … Blayney, D. W. (2017). Improving care with portfolio of physician-led cancer quality measures at an academic center. JOURNAL OF CLINICAL ONCOLOGY, 35(8). -
Preparing for bundled payments in urology: Defining episodes, evaluating variations in care, and demonstrating improved value.
Skinner, E. C., Tang, N., Stevenson, K., Guo, D., Hu, J.-S., Hendershott, J., & Krishna, P. (2017). Preparing for bundled payments in urology: Defining episodes, evaluating variations in care, and demonstrating improved value. JOURNAL OF CLINICAL ONCOLOGY, 35(8). -
Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation
Mitra, A. P., Fairey, A. S., Skinner, E. C., Boorjian, S. A., Frank, I., Schoenberg, M. P., … Daneshmand, S. (2019). Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 37(1), 48–56. -
IMPLEMENTATION OF A REDUCED OPIOID UTILIZATION PROTOCOL FOR RADICAL CYSTECTOMY
Greenberg, D., Kee, J., Stevenson, K., Van Zyl, E., Dugala, A., Prado, K., … Shah, J. (2019). IMPLEMENTATION OF A REDUCED OPIOID UTILIZATION PROTOCOL FOR RADICAL CYSTECTOMY. JOURNAL OF UROLOGY, 201(4), E1196–E1197. -
Predictors of Recurrence, Progression-Free and Overall Survival Following Open Versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Follow-Up.
Venkatramani, V., Reis, I. M., Castle, E. P., Gonzalgo, M. L., Woods, M. E., Svatek, R. S., … Parekh, D. J. (2019). Predictors of Recurrence, Progression-Free and Overall Survival Following Open Versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Follow-Up. The Journal of Urology, 101097JU0000000000000565. -
Implementation of a Reduced Opioid Utilization Protocol for Radical Cystectomy
Greenberg, D. R., Kee, J. R., Stevenson, K., Van Zyl, E., Dugala, A., Prado, K., … Shah, J. B. (2020). Implementation of a Reduced Opioid Utilization Protocol for Radical Cystectomy. BLADDER CANCER, 6(1), 33–42. -
Co-Manifestations of Genital Neurofibromatosis in a Patient with Neurofibromatosis Type 1.
Ku, S., Balasubramanian, A., Kao, C.-S., Eisenberg, M. L., & Skinner, E. C. (2020). Co-Manifestations of Genital Neurofibromatosis in a Patient with Neurofibromatosis Type 1. Urology. -
Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer.
Bhambhvani, H. P., Zamora, A., Shkolyar, E., Prado, K., Greenberg, D. R., Kasman, A. M., … Shah, J. B. (2020). Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer. Urologic Oncology.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions »
- Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants »
- S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer »
- Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma »
- Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer »
- Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial »
- S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer »
- ADAPT-BLADDER: Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder »
Practice Locations
Urology Clinic Palo Alto, CA
Palo Alto, CA
Urology Clinic
1000 Welch Road, Garden Level
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Urologic Cancer Program in Palo Alto Palo Alto, CA
Palo Alto, CA
Urologic Cancer Program in Palo Alto
875 Blake Wilbur Drive
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Urologic Cancer Program in San Jose San Jose, CA
San Jose, CA
Urologic Cancer Program in San Jose
2589 Samaritan Drive
San Jose , CA 95124
Make An Appointment More Clinic Information » Getting Here »Patient Reviews
(231 reviews)
Dr. E. Curlee & Lillian Shiba, PA have been treating me for cancer since early 2016 until my previous when no cancer was detected with the utmost respect & honesty that should be & has always been the gold standard with the entire team. The same holds true for Abha Khandelwal, MD.
Dr. Skinner provides the service needed to treat my health condition. Tends to be limited with time. However, my bladder cancer treatment is going the way we want, success.
Both Dr. Skinner & staff.
Dr. Skinner is a big reason why I come to Stanford Health Care, she is excellent in her expertise and her care of patients.
I am so fortunate & have Dr. Skinner as my doctor.
Dr. Skinner/always explains everything very well.
Excellent all.
Dr. Skinner is always punctual spends time listening and explaining tests & care. Dr. Skinner also ensures that protocols and procedures are taken care of... follow up app.
Wonderful doctor!
Wonderful care provider.!!
My doctor Skinner is the best of the best. She has managed my care wonderfully so kind & caring!
Dr. Skinner is the BEST! She is very caring, very down-to-earth in her questions & explanations. She is also very communicative with the family of her patients. We always felt we were in the BEST of hands!
Dr. Skinner is one of her kind.
Dr. Skinner has been my care provider for only a short time, but I have a positive approach to my treatment plan etc. She inspires confidence.
Good.
Dr. Skinner is the best! Bar none!
Dr. Skinner is outstanding!
Dr. Skinner is fantastic!!
Dr. Skinner & her team members are consummate professionals.
Very busy person but tries to listen & responds - hard to reach but hen you get her she's there for you!
You could not get a better doctor than Dr. Skinner. She is knowledgeable, patient, caring, etc. Wish she could be my PRIMARY! I have been seeing her for 5 years.
She seems quite busy but I have great confidence in her treatment.
Dr. Skinner always gives excellent & empathetic medical care.
Dr. Skinner is the best!
I am very satisfied having Dr. Skinner provide treatmt, consultation, etc.
Perhaps a bit more detail re: follow on/maintenance care would be useful - That said - Excellent professional care.
Superior!
Dr. Skinner is wonderful.
Dr. Skinner is excellent.
My appointment time with Dr. Skinner is spent well. My questions are answered, and leave well-satisfied.
Dr. Skinner is the kindest most competent and comforting human I know. She could walk into the halls of hell and every soul would feel as though it had gone to Heaven after all.
Dr. Skinner reviewed my reports and tests in advance. The meeting time was very productive and I left feeling more comfortable about my care plan.
Dr. Skinner was excellent.
Dr. Skinner is excellent, communicates very well, doesn't talk down to me.
Dr. Skinner is amazing. I fully trust her & I am so thankful.. that she's my physician.
Dr. Eila Skinner is an excellent physician and a wonderful person. I come from Southern California to get her professional opinion concerning my condition & treatment.
Dr. Skinner was very nice and explained everything in detail.
Dr. Skinner was terrific at sharing treatment options with me. She was generous with the time she spent with me to discuss treatment options.
Wanted more information based on tests before recommending options. My kind of doctor.
Dr. Skinner & her staff are exceptional at keeping me informed & striving for the best care solutions to help me. World-class care.
I feel very confident in Dr. Skinner.
Explained my condition so that I understood, was "A" one.
Dr. Skinner is great!
Dr. Skinner provided an excellent, understanding/knowledge of my problem. I found the entire experience very beneficial in that I was reassured as the ongoing management of my cancer.
I am very grateful for the work they did to correct a diagnosis, very _____ or incorrect. 4. _____ see appointments.
Stanford is the best care and concern for me.
On a scale of 1-10 Dr. Skinner is a (25). I have the utmost confidence in her. I also feel very lucky to have her as my doctor.
By doctors and nurses everybody do helps which I needed.
Great, open, easy to talk with.
Dr. Skinner is the best - don't ever let her retire.
I can't give Dr. Skinner enough praise, she is the best in what she does! A real professional!
Dr. Skinner, Dr Shkolyar, & Qun Ma all spent an enormous amount of time with us. They way they treated us gave us great confidence in the whole team.
I owe Dr. Skinner my life. She's absolutely the VERY best!! I've recommended her to anyone who can use her expertise!
Dr. Skinner is outstanding!!
It was one of the most positive experiences I've had with a doctor in my life.
She is ALWAYS in a hurry. She is very hard to reach by phone.
Dr gave me a positive outlook on my future treatment. It was appreciated.
Doctor was thorough, supportive and encouraging. Incredible bedside manner! Trust her completely!
Dr. Skinner was awesome. Dr. Sun was very nice also.
Dr. Skinner very informative and experienced doctor. waiting for my main treatment.
Outstanding doctor - all aspects.
Dr. Skinner is exceptional and explaining and discussing the treatment options. She always convey the greatest care for her patients (she treated my husband before also). We have the highest regard and trust in her.
Dr Skinner seems like an excellent physician.
Dr. Skinner was thoughtful, kind and thorough in discussing my diagnosing of cancer.
Dr. Skinner came to same in the hospital on her day off to make sure I was alright. Kelly Bugas (BMT) also came in to see me - sure means a lot when you're not up to par.
Dr. Eila Skinner is EXCELLENT!
Very appreciative of the details and care that Dr. Eila Skinner showed (urology oncology).
LOVE Dr. Skinner!
Best doctor I've ever seen! Exceptional in every aspect what every dr. should strive to be.
I am very satisfied with the care I am receiving.
Dr. Skinner is the BEST!!!
Wonderful doctor - Seems to really care about patient.
the communication was good.....questions anwered!
Top to bottom 1st class operation!
Dr. Skinner is the best!!
Dr. Skinner & her staff are phenomenal, outstanding, the very, very best of the best. Kind, courteous & caring. Love Angela!
I felt I was shown total respt. and she made sure she answered questions posed by husband and me. She instilled confidence and compassion.
Dr. Skinner and her staff are phenomenal.
Dr. Skinner is 1st & foremost an excellent person, as to her medical knowledge it is incomparable! Her personal & professional caring & integrity is evident & most appreciative.
In addition to the fact that Dr. Skinner is clearly one of the most gifted surgeons in the country/world, she somehow made me feel as though everything in the universe was going to be just fine every time she entered the room. Her demeanor is always kind, hopeful, and uplifting.
Best experience possible.
Very excellent communication with dr. & staff. Dr. Skinner.
ALWAYS an outstanding experience!! I feel blessed to be under Dr. Skinners care.
Absolutely first rate!
Dr. Skinner is great!
Dr. Skinner spent more time with me during this visit than my regular urologist has spent in the past 3 yrs.
Superb treatment. Can I take Dr. Skinner home with me?
Dr. Skinner was very kind and helpful in helping me understand my problems.
Dr. Skinner is an exceptionally good doctor; the rare combination of being caring AND competent.
Highly professional, friendly, knowledgeable, great personality doctor!
Completely satisfied with all aspects of the time I have spent at Stanford Med Center.
Dr. Skinner is as good as there is for my condition and would highly recommended her.
Dr. Skinner is the best - both a great surgeon and a real human being.
Dr. Skinner displays great bedside manner!
Dr. Skinner is the best!
already recommended to numerous people
The service that I have gotten from Dr. Skinner's team is beyond Very Good. My only regret is not going to Stanford and Dr. Skinner sooner.
Dr. Eila SKINNER is one of those people that makes you feel glad to be in the room that she has entered even before she says a single word. Then, it only gets better from there.
Dr. Skinner is very kind & caring to her patients. I love her demeanor. I always have to have me every 3 months hug!
Exceptional.
I have most confidence of this dr. than all dr. in past.
Dr. Skinner - tops!!
Dr. Skinner is an amazing doctor. I am so lucky to have her as my doctor. She is simply "the best."
We know that Dr. Skinner is the top of her field and were thrilled to be able to see her with only a weeks wait. We have absolute confident in her abilities and were amazed at her abilities were amazed at her caring presence and willingness to answer any and all questions thoroughly.
very satisfied with my initial consultation
The visit was unlike anything I've experienced! Everything dealt with professionally and thoroughly!! I left feeling supported - important - and positive about my outcome! Dr. Skinner and PA - outstanding!!
Very impressed with concern and caring up & down the line.
Very good.
I had bladder CANCER - I couldn't have made it (treatments & operation without the wonderful care of your staff.)
Everyone was nice to me.
Dr. Skinner will be performing surgery next year and is helping us through my husband's chemo which he's having locally. Two of her nurses and assistants have checked in with us more than once.
Dr. Skinner and staff are exceptional. I have total confidence in them.
This care provider always speaks in language I can understand but I am fluent in medical jargon.
Dr. Skinner is excellent at communicating and making a patient feel comfortable.
Best of the best. Dr. Skinner & her staff.
Doctor Skinner was attentive explained medical diagnosis. Very happy to have appointment in clinic. Doctor was compassionate and informative.
Very good.
Dr. Skinner is the best urology oncologist!
Dr. Skinner and those whom she trains or who serve me through her are nothing short of marvelous. I was fortunate indeed to have had her supervision of an otherwise grim situation.
Very good.
Eila Skinner MD is awesome!
Love Dr. Skinner! She was compassionate and smart.
The doctor was great I under stood what she was talking about.
The almost best best!
Good.
I constantly refer others to Dr. Skinner. She is the very best!!
Great outcome.
Promised response did not happen - 1 week!!
Dr. E Skinner is excellent!
Excellent after visit communication to myself and referring physician.
Good.
Very smart & articulate.
Biggest issue was that nobody told me I had cancer until she handed me the booklet. I probably should have figured it out, but everyone acted like I already knew....
Dr. Dalman & Dr. Skinner were both MAGNIFICENT.
The best!
Best care in the world!
Excellent experience.
Everyone was and is so helpful.
Amazed at how well the treatment worked!
EXCELLENT.
Excellent.
Dr. Skinner always spends as much time as I need w/me.
Dr. Skinner is the best!
This was my 1st visit and we were called before the appt. time and saw 3 different care providers including Dr. Skinner. I was impressed.
Extremely good.
Excellent experience.
All good pleasant experiences!
I have and will recommend Dr. Skinner. I feel very blessed to have her for my doctor!
My husband and I found Dr. Eila Skinner to be very pleasant and understanding. We bonded with her immediately. I feel very blessed to have Dr. Skinner performing my bladder removal surgery.
Very empathetic and took time to answer every one of many questions.
Dr. Skinner was great. That's why we went to Stanford Health Care.
Eila Skinner MD head of urology at Stanford is what every doctor should be - friendly courteous, caring and unaffected. She is the highly skilled, but easily relates to her patients.
Dr. Skinner is truly awesome! Knows her field and explains things very well.
Dr. Skinner is an excellent surgeon and was very patient and helpful in answering all of my questions that I presented to her. Stacy, RN was also very professional and helpful with all of questions re: my stoma, urostomy bags, etc.
Dr. Skinner is great.
Again, outstanding service; attentiveness, concern, answers to questions - great.
I was very satisfied with Dr. E. Skinner.
Dr. Skinner and her staff are fantastic!!
Dr. Skinner was very good. Very polite and down to earth.
Dr. Skinner is outstanding!!
They forgot my father in the waiting room. Appt. was at 2:00 & they forgot till 3:00 till I said something.
Very pleased.
This time she was in a hurry and I worried that she hadn't had enough time to read my scan because it had only been a short while before I went to my appt. after having had the scan. But, I guess I was okay!
Dr. Skinner is simply an amazing doctor. She is caring, knowledgeable & very informative. I know I am getting the very best care.
I felt very confident that I was getting the best care possible.
utmost confidence. I rate Dr. Skinner as the very very very best doctor and am honored and thrilled that she is my doctor and know that I am in most competent hands.
Best of care.
Dr. Skinner is THE best!!!
Dr. Skinner as an expert in her field has the ability to inspire confidence and yet maintains a pleasant manner including the patient in the conversation. She has an outstanding "bedside manner."
I have referred several patients to Dr. Skinner - She is without equal!
I have recommended Dr. Skinner to several of my friends. I have a friend who is changing her insurance at the end of the year so she can see Dr. Skinner. I wouldn't trade Dr. Skinner for a million dollars.
Dr. Skinner was very knowledgeable and informative in describing my condition.
great care
As good as it can be.
Dr. Skinner is a wonderful provider and lucky to have such a doctor.
Dr. Skinner is excellent.
the best, the absolute best.
Dr. Skinner and the resident, Andrew, were OUTSTANDING with explaining all to me.
Dr. Skinner provided my husband and I with the information we needed for my health issues as well as our expectations with comfortable explanations and diagrams that were easily understood. I would highly recommend her care for anyone else in my situation.
I had the utmost faith in Dr Skinner and feel deeply grateful that I could work with her!
Great Doctor
Dr. Skinner is great!
Wow! Dr. Skinner is wonderful.
Nothing but kindness and professionalism from the entire staff.
I saw two doctors & a PA & all were excellent.
Excellent doctor. Excellent nurses & excellent staff.
Dr Skinner and her staff are the best!
knowledge unsurpassable and kind and caring and truly listens to the patient given current situation actually felt a bit calmer after speaking to Dr. Skinner!
Responds back to me on test results promptly.
Dr. Skinner is fabulous!
Dr. Skinner is the BEST!
I feel myself very lucky to a team of this caliber.
We are fortunate to have DR Skinner as treating physician. Have utmost confidence in her. Resident intern also excellent - made us feel comfortable and hopeful.
I cannot say enough about Dr. Eila Skinner - she is THE BEST!
all staff was excellent.
I thank Doctor Skinner for being very clear beside being very gentle and caring.
Dr. Eila Skinner is the BEST!!
My provider was very informative, knowledgeable - spent a lot of time with me.
Dr. Skinner is the only doctor I really trust at Stanford.
Dr. Skinner is skilled, kind and interested in her patients.
Dr. S. Kinner is the best!
Dr. Skinner is an excellent communicator as well as a surgeon.
I love Dr. Eila Skinner - I've been her pt. since 1992 @ USC. I drove 7 hrs. just to have her do my cysts exam - SHE'S GREAT!
Care provider is super. Put my mind at ease. Felt very at ease when I left office.
I can't say enough good things about Dr. Skinner. She is warm, caring, compassionate and highly competent.
The care, concern, explanation, etc., has always been excellent.
Dr. Skinner is always concerned and listens if I have any questions. I am grateful for her skill, she is an excellent Dr.
Dr. Eila Skinner is OUTSTANDING. I trust her & appreciate her care, concern, professionalism & knowledgeable.
Excellent doctor & staff.
Dr. Skinner & the resident were both extremely knowledgeable and competent. Highly recommend them!
I have received the best possible care any patient could receive.
I worked both with Dr. Skinner as well as her resident. Both were excellent -- and attentive to my questions/needs.
Very impressed with everyone.
good
Excellent.
The best Dr. Skinner.
Dr. Skinner is a great doctor!
I think Dr. Skinner is a very intelligent, exceptional doctor. She is always pleasant and takes the time to explain everything.
DR. Skinner is awesome. She is so smart and kind and caring! I just love her & Stacey Cox her nurse. They are the BEST,
So fortunate to have Dr. Skinner as my physician/surgeon she is great!
Very professional, friendly I was impressed with her knowledge.
Best care provider I've had.
Dr. Skinner was able to resolve my medical problem when previous doctors at PAMF were unable to do. She is the best!
100% super.
I was very fortunate to have Dr. Skinner as my surgeon - she is fantastic!
GOOD.
The entire Stanford experience has been great.
All exceptional.
Everybody is EXCELLENT! Eila Skinner is why I use Stanford!
Dr. Skinner outstanding skill & compassion.
Dr. Skinner was amazing. I trust her 100%.
View More »
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
- Send referrals online
- View referral status
- Access medical records